Pyrimido[4,5-b]quinoline-3(4H)-acetamide, 6,7,8,9-tetrahydro-N-(6-methoxy-2-benzothiazolyl)-4-oxo-

Pyrimido[4,5-b]quinoline-3(4H)-acetamide, 6,7,8,9-tetrahydro-N-(6-methoxy-2-benzothiazolyl)-4-oxo- manufacturers

Pyrimido[4,5-b]quinoline-3(4H)-acetamide, 6,7,8,9-tetrahydro-N-(6-methoxy-2-benzothiazolyl)-4-oxo- Basic information

Product Name:	Pyrimido[4,5-b]quinoline-3(4H)-acetamide, 6,7,8,9-tetrahydro-N-(6-methoxy-2-benzothiazolyl)-4-oxo-
Synonyms:	Pyrimido[4,5-b]quinoline-3(4H)-acetamide, 6,7,8,9-tetrahydro-N-(6-methoxy-2-benzothiazolyl)-4-oxo-;SARS-CoV-2 nsp13-IN-6
CAS:	951588-85-5
MF:	C21H19N5O3S
MW:	421.47
EINECS:
Product Categories:
Mol File:	951588-85-5.mol

Pyrimido[4,5-b]quinoline-3(4H)-acetamide, 6,7,8,9-tetrahydro-N-(6-methoxy-2-benzothiazolyl)-4-oxo- Chemical Properties

density	1.54±0.1 g/cm3(Predicted)
pka	9.06±0.70(Predicted)

Safety Information

MSDS Information

Pyrimido[4,5-b]quinoline-3(4H)-acetamide, 6,7,8,9-tetrahydro-N-(6-methoxy-2-benzothiazolyl)-4-oxo- Usage And Synthesis

Uses	SARS-CoV-2 nsp13-IN-6 (compound C5) is a potent SARS-CoV-2 non-structural protein 13 (nsp13) inhibitor with IC50 values of 27 and 33 μM for ssDNA+ ATPase and ssDNA- ATPase. SARS-CoV-2 nsp13-IN-6 can be used for researching anti-COVID-19[1].
References	[1] Yazdi AK, et al. Kinetic Characterization of SARS-CoV-2 nsp13 ATPase Activity and Discovery of Small-Molecule Inhibitors. ACS Infect Dis. 2022 Jul 13. DOI:10.1021/acsinfecdis.2c00165

Pyrimido[4,5-b]quinoline-3(4H)-acetamide, 6,7,8,9-tetrahydro-N-(6-methoxy-2-benzothiazolyl)-4-oxo- Preparation Products And Raw materials

Tag:Pyrimido[4,5-b]quinoline-3(4H)-acetamide, 6,7,8,9-tetrahydro-N-(6-methoxy-2-benzothiazolyl)-4-oxo-(951588-85-5) Related Product Information

Brequinar Ritonavir SARS-CoV-2 3CLpro/3C-like protease protein SARS-COV-2 S protein RBD (194A.A, HEK293, HIS) SARS-COV-2 S protein RBD (HEK293, FC) SARS-COV-2 S protein RBD (N501Y, K417N, E484K, HEK293, HIS)